Showing 1 - 10 of 69
-savings, and that patients' copayments decrease despite the extra surcharges under RP. -- pharmaceuticals ; regulation ; generic …
Persistent link: https://www.econbiz.de/10008749029
Persistent link: https://www.econbiz.de/10009270541
generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …. -- pharmaceuticals ; pharmacies ; generic substitution …
Persistent link: https://www.econbiz.de/10009691207
Persistent link: https://www.econbiz.de/10009762378
Persistent link: https://www.econbiz.de/10008655517
Persistent link: https://www.econbiz.de/10014426057
generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …
Persistent link: https://www.econbiz.de/10013088216
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10013139185
Persistent link: https://www.econbiz.de/10014297008
Persistent link: https://www.econbiz.de/10013350399